Release Date: 22/08/22 09:56 Summary: Sale of U.S. Solar Assets Price Sensitive: Yes Download Document 301.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%